anti-stromelysin ribozymes (Ribozyme)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanti-stromelysin ribozymes (Ribozyme)
Drug Alias Nameribozymes (Ribozyme)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > RibozymeSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionMatrix metalloproteinase 3 inhibitors
TargetsMatrix metalloproteinase 3
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSirna Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSirna Therapeutics IncParke-Davis Corp
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A